[HTML][HTML] Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland
Background As vaccination coverage against SARS-CoV-2 increases amidst the emergence
and spread of more infectious and potentially more deadly viral variants, decisions on timing …
and spread of more infectious and potentially more deadly viral variants, decisions on timing …
[HTML][HTML] Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines
L Lu, LL Chen, RRQ Zhang, OTY Tsang, JMC Chan… - …, 2022 - thelancet.com
Summary Background SARS-CoV-2 Omicron variant evades immunity from past infection or
vaccination and is associated with a greater risk of reinfection among recovered COVID-19 …
vaccination and is associated with a greater risk of reinfection among recovered COVID-19 …
Elevated risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variants compared with Alpha variant in vaccinated individuals
SP Andeweg, H Vennema, I Veldhuijzen… - Science Translational …, 2022 - science.org
The extent to which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants of concern (VOCs) break through infection-or vaccine-induced immunity is not well …
variants of concern (VOCs) break through infection-or vaccine-induced immunity is not well …
[HTML][HTML] A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open …
A Chang-Monteagudo, R Ochoa-Azze… - The Lancet Regional …, 2021 - thelancet.com
Background As a first step towards a vaccine protecting COVID-19 convalescents from
reinfection, we evaluated FINLAY-FR-1A vaccine in a clinical trial. Methods Thirty COVID-19 …
reinfection, we evaluated FINLAY-FR-1A vaccine in a clinical trial. Methods Thirty COVID-19 …
Omicron–the new SARS‐CoV‐2 challenge?
A Lino, MA Cardoso, P Martins‐Lopes… - Reviews in Medical …, 2022 - Wiley Online Library
SARS‐CoV‐2 virus has infected nearly 300 M people worldwide and has been associated
with over 6 M deaths by March 2022. Since the virus emergence in December 2019 in …
with over 6 M deaths by March 2022. Since the virus emergence in December 2019 in …
[HTML][HTML] Assessing the impacts of COVID-19 vaccination programme's timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African …
Y Liu, SR Procter, CAB Pearson, AM Montero… - BMC medicine, 2023 - Springer
Background The COVID-19 vaccine supply shortage in 2021 constrained roll-out efforts in
Africa while populations experienced waves of epidemics. As supply improves, a key …
Africa while populations experienced waves of epidemics. As supply improves, a key …
One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk
With newly rising coronavirus disease 2019 (COVID-19) cases, important data gaps remain
on (i) long-term dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
on (i) long-term dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology
JM Caldwell, X Le, L McIntosh, MT Meehan… - Paediatric Respiratory …, 2021 - Elsevier
Mathematical modelling has played a pivotal role in understanding the epidemiology of and
guiding public health responses to the ongoing coronavirus disease of 2019 (COVID-19) …
guiding public health responses to the ongoing coronavirus disease of 2019 (COVID-19) …
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery–a comprehensive systematic review and meta-analysis
This study aims to estimate the prevalence and longevity of detectable SARS-CoV-2
antibodies and T and B memory cells after recovery. In addition, the prevalence of COVID-19 …
antibodies and T and B memory cells after recovery. In addition, the prevalence of COVID-19 …
[HTML][HTML] Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here
DT Halperin, N Hearst, S Hodgins, RC Bailey… - BMC public health, 2021 - Springer
Background Strategies to control coronavirus 2019 disease (COVID-19) have often been
based on preliminary and limited data and have tended to be slow to evolve as new …
based on preliminary and limited data and have tended to be slow to evolve as new …